214 Companies Push a Rule 26 Litigation Funding Disclosure Requirement Onto the October Agenda

The ask landed three days ago and the committee takes it up on 21 October

On 14 September 2026, a coalition that Unified Patents counts at 214 companies filed a letter with the Advisory Committee on Civil Rules asking it to draft and propose a uniform rule requiring disclosure of nonparty litigation funding contracts in federal civil cases. The Rule 26 litigation funding disclosure requirement they want already exists in draft form as suggestion 26-CV-8, filed on 10 March 2026 by Lawyers for Civil Justice and the U.S. Chamber Institute for Legal Reform, and the committee takes up its next steps at a hybrid meeting in Washington on 21 October — which means the only thing that changed this month is the weight of the corporate signature block, not the text on the table.

That distinction matters more than the headline count. The committee has been sitting on this question since it authorised a Third-Party Litigation Funding subcommittee in late 2024, and the file now holds submissions from the proponents, from the funding industry, and from the plaintiffs' bar. What the 214 companies have bought is not a rule. It is pressure on a body that answers to the Rules Enabling Act, and under that statute nothing agreed in October 2026 can bind a litigant before December 2029 at the earliest.

What did the 214 companies ask the Advisory Committee on Civil Rules to do?

They asked it to write a rule. The operative request, as reported by IPWatchdog, is that the committee "draft and propose a straightforward, uniform rule for disclosure of nonparty litigation funding contracts" — a request for a national requirement rather than for further study, further hearings, or a best-practices handbook. The letter's supporting argument is that courts, litigants and the public presently have no reliable way to identify nonparty funders who take a share of judgments, and that judges have begun asking about funding arrangements case by case in large Multidistrict Litigation (MDL) proceedings, Class Action dockets and patent cases without any common standard to apply.

The letter's own framing is blunter than the procedural argument suggests: it says courts, litigants and the public have no way to identify nonparty funders who take a share of judgments on what it calls a "clandestine basis."

The coalition's second argument is about uniformity rather than transparency, and it is the stronger one on the merits of rulemaking. Individual districts and individual judges have adopted their own local rules and standing orders on nonparty funding. The signatories say that patchwork confuses courts and litigants, invites forum shopping, and cuts against the Advisory Committee's whole institutional purpose, which is to supply one set of procedures for every federal district. That is an argument a rules committee is built to hear, and it is materially different from the substantive claim that funding is harmful.

The letter is organised and backed by Lawyers for Civil Justice, the U.S. Chamber Institute for Legal Reform, the American Property Casualty Insurance Association and Unified Patents. The signatories are not a single-sector bloc: the coalition spans food and agriculture, technology, healthcare, insurance, financial services, energy, transportation, logistics, automotive, aerospace, retail, hospitality and manufacturing, and includes small businesses as well as the household names. On the signatory list, Insurance Journal names Allstate, AIG, Chubb, State Farm, Liberty Mutual, Nationwide, Travelers and AXA XL; Unified Patents' summary of the broader list names Amazon, Google, Microsoft, Meta, ExxonMobil, Ford, Anthropic and OpenAI among the technology and industrial signatories, alongside pharmaceutical firms and manufacturers. Coverage elsewhere describes the group as "more than 200 companies"; 214 is the figure Unified Patents published on the day.

Would the proposed Rule 26 amendment require disclosure of litigation funding agreements?

Yes — the agreement itself, not merely the funder's name. The 26-CV-8 proposal would add to the list of required initial disclosures in Rule 26(a)(1)(A) a duty to give "the name, address, and telephone number of any non-party individual or entity (other than counsel of record) that, whether directly or indirectly, is providing funding for the action and has a financial interest therein and, for inspection and copying as under Rule 34, any agreement" relating to that funding. Two features of that drafting do the real work.

The first is that disclosure is automatic. Putting the duty in Rule 26(a)(1)(A) means it attaches at the outset of the case as part of initial disclosures, without a motion, without a showing of relevance, and without the case-by-case discoverability fight that has consumed the existing case law. The second is the Rule 34 hook: the funding agreement becomes available for inspection and copying, so the disclosure reaches the economics — the funder's percentage, the priority of repayment, any consent rights over settlement — and not just the identity. The proponents say the design is modelled on the Northern District of California's Local Rule 3-15, preserves judicial discretion, and protects privileged material. Whether it does the last of those is precisely what the funding industry disputes.

Do federal courts already require disclosure of third-party litigation funding?

Some do, in different ways, and that is the problem the letter is built on. There is no general federal requirement. What exists is a set of district-specific and judge-specific regimes of markedly different scope, and a body of discovery rulings in which Third-Party Litigation Funding agreements are sometimes discoverable and sometimes shielded as work product.

Regime	Scope	What must be disclosed	Adopted
N.D. Cal. Local Rule 3-15	District-wide, all civil cases	Nonparty persons or entities with a financial interest of any kind in the subject matter or in a party; the existence of a funding arrangement, not the agreement itself absent a court order	2017
D.N.J. Local Civil Rule 7.1.1	District-wide, all civil cases	Third-party funding arrangements, including a description of the funder's financial stake in the case	2021
Chief Judge Colm Connolly standing order, D. Del.	That judge's courtroom only	Funder identity, the funder's interest, and terms conditioning litigation or settlement decisions on funder approval	April 2022
Ad hoc case management orders	Individual MDLs, class actions and patent cases	Whatever the presiding judge asks for	Ongoing
Proposed Rule 26(a)(1)(A) (26-CV-8)	Every federal district, every covered civil action	Funder identity and contact details plus the funding agreement, for inspection under Rule 34, as an initial disclosure	Not adopted

Two points a practitioner should take from that table. The strongest existing regimes are narrower than the proposal in a way that is easy to miss: N.D. Cal.'s Local Rule 3-15 requires the fact of funding, not the contract, unless the court orders otherwise. And the proposal is broader than the local rules in the one dimension that matters most to a funded plaintiff's counsel — it produces the document by default.

The other thing already on the books is a near miss. Rule 16.1, the first federal rule written specifically for MDL practice, took effect on 1 December 2025 after years of drafting. It was the obvious vehicle for an MDL funding-disclosure provision. The final text carried none.

The docket is the real story: 28 signatories, then 124, then 214

The most useful record here is not the press coverage but the Advisory Committee's own suggestion docket, which shows a campaign escalating in step and a committee that has not moved at the same rate.

Suggestion	Submitted by	Date	Ask
21-CV-U	28 companies	28 September 2021	Rule 26 disclosure of third-party litigation funding
22-CV-M	LCJ and ILR	2022	Amend Rule 16(c)(2) to promote funding disclosure at case management
23-CV-M	35 organisations	2023	Funding disclosure
24-CV-U	124 companies	2024	Rule 26 disclosure of third-party litigation funding
25-CV-H	American Association for Justice	2025	Plaintiffs' bar position
25-CV-O	International Legal Finance Association	2025	Funding industry position opposing mandatory disclosure
25-CV-R	12 attorneys and advisors	15 October 2025	Third-party litigation funding
26-CV-8	LCJ and ILR	10 March 2026	Proposed amendment to Rule 26(a)(1)(A) with rule text
26-CV-30	LCJ and U.S. Chamber	pending as of 8 September 2026	Rule 26 funding disclosure — "disclosure to whom?"

The 26-CV-30 framing is the most informative entry on that list and the one no competing account has picked up. By September 2026 the proponents are no longer arguing about whether disclosure should be required. They are arguing about the audience: disclosure to the opposing parties, disclosure to the judge in camera, or disclosure on the public docket. That is the choice that decides whether a rule is a case-management tool or a competitive-intelligence pipeline, and it is the question the committee will be working on 21 October.

When would a Rule 26 litigation funding disclosure requirement actually take effect?

Not before 1 December 2029, and that assumes nothing slips. Federal civil rules move through a fixed statutory sequence under the Rules Enabling Act, and every stage has to happen in order.

Stage	Earliest plausible timing
Advisory Committee agrees on draft rule text	21 October 2026 meeting, or spring 2027
Standing Committee approves publication for comment	June 2027
Public comment period, including hearings	August 2027 to February 2028
Advisory Committee revises and approves final text	spring 2028
Standing Committee and Judicial Conference approve	June to September 2028
Supreme Court transmits to Congress	by 1 May 2029
Rule takes effect absent congressional action	1 December 2029

Practitioners should read that table as the answer to a planning question, not a reason to discount the proposal. A funded MDL inventory built in 2026 will still be unresolved in 2029. Funding agreements signed today routinely run longer than three years. The relevant risk is not that the rule arrives tomorrow; it is that agreements being drafted now will be read under a disclosure regime that did not exist when they were negotiated — and that the interim period will be governed by exactly the patchwork of local rules and standing orders the letter complains about.

There is a second track that could move faster. The Litigation Funding Transparency Act of 2026, S. 3826, introduced by Senators Grassley, Tillis, Kennedy and Cornyn, would amend title 28 to require disclosure of third-party funding in certain actions and impose reporting obligations on foreign funders. Legislation is not bound by the Rules Enabling Act calendar. It is, however, bound by the ordinary difficulty of moving a contested civil-justice bill, and no version has yet cleared committee.

Why litigation funders oppose mandatory disclosure

The International Legal Finance Association's submission, docketed as 25-CV-O, makes three arguments that will shape the October discussion whether or not the committee accepts them.

The distributional argument is that a blanket disclosure duty falls hardest on the litigants least able to absorb it. ILFA's position is that mandatory disclosure would disproportionately burden small businesses and individual claimants while leaving the financing arrangements of well-capitalised corporate defendants untouched — that the rule would single out the one funding form most likely to level the playing field between a Negative-Value Claim holder and a repeat-player defendant. Insurance and corporate balance-sheet capacity are not disclosed as initial disclosures; the asymmetry is real, and the proponents' answer is that a funder's contingent interest in the recovery is structurally different from a defendant's capital.

The privilege argument is narrower and more technically serious. ILFA contends that producing the funding agreement forces disclosure of privileged strategic work product and case-budget information, because a funding contract typically embeds a case assessment, a damages model and a litigation budget. The 26-CV-8 proposal's answer is that it "protects parties' assertions of privilege," which leaves the redaction fight to be conducted case by case — precisely the sort of per-case litigation the uniformity argument was supposed to eliminate.

The third argument is a credibility contest rather than a legal one. The proponents' filings point out that funders tell the Advisory Committee they exercise no control over financed lawsuits while telling investors and, in some settings, courts something closer to the opposite. That inconsistency is the single most damaging thing in the record for the funding industry, because the committee's jurisdiction is case management: if funders genuinely have no influence over litigation or settlement decisions, the case for a disclosure rule weakens considerably, and if they do, it strengthens.

How would a funder disclosure rule change MDL and mass tort practice?

Most concretely, it would move funding from something a Mass Tort defendant can only guess at to something it receives in the first thirty days. Three consequences follow.

Leverage in aggregate settlement changes. A defendant negotiating a Global Settlement across a 6,000-claim inventory currently prices the plaintiffs' side reserve by inference. Knowing the funder's percentage, the repayment priority and any consent rights converts that inference into arithmetic: it reveals the floor below which claimants' counsel cannot settle without leaving the funder unpaid, and it reveals which portions of an inventory are financed at all.

Common Benefit Fund and lien administration get more transparent and more contested. Funding disclosure sits adjacent to Medical Lien resolution and to the Qualified Settlement Fund (QSF) mechanics through which mass tort proceeds are distributed. A rule that produces the funding agreement makes visible how much of a claimant's gross recovery is already committed before a lien is even negotiated.

Claim-generation economics come under scrutiny. The New York Times reporting by Ellen Gabler, Robert Gebeloff and Julie Tate that the letter's proponents rely on found that the largest consumer legal funders bundle cash advances to personal injury plaintiffs into asset-backed securities — more than two dozen deals since 2020, raising $2.8 billion from investors, with six funders accounting for more than 90 per cent of advances by industry trade-group figures. The Times reported advances carrying fees and interest averaging 35 to 45 per cent a year, and one New York plaintiff who took $76,500 in advances owing at least $1.4 million by settlement. Those figures are the reason disclosure has stopped being a purely procedural debate. For scale on the commercial side, Westfleet Advisors put new U.S. commercial litigation finance commitments at $2.8 billion in 2025, a 23 per cent rebound, against $16.1 billion of assets under management across 39 active funders.

Would a federal disclosure rule reach mass arbitration funding?

No, and this is the structural hole in the entire project. The Federal Rules of Civil Procedure govern civil actions in the United States district courts. A Rule 26(a)(1)(A) initial-disclosure duty attaches to a case on a federal docket; it does not attach to a Demand for Arbitration, to a Batching queue, or to ten thousand individual claims administered by a private provider. A funded Mass Arbitration campaign would sit entirely outside the rule.

Nor do the provider rulebooks fill the gap. The American Arbitration Association (AAA) Mass Arbitration Supplementary Rules, effective 15 January 2024, and the JAMS Mass Arbitration Procedures, effective 1 May 2024, were both written to police claimant identity and counsel verification — name, address, email, and a declaration from counsel that the information is true. Neither requires a claimant or claimants' counsel to identify a funder or produce a funding agreement. Arbitral disclosure obligations in the United States run to the neutral's conflicts, not the claimant's capital stack.

Put those two facts together and the consequence is uncomfortable for both camps. If the Advisory Committee writes a mandatory Rule 26 disclosure duty and the providers do not follow, the rule creates a disclosure-free lane for funded aggregate claiming: the same funder financing the same inventory faces an automatic production obligation in a Multidistrict Litigation (MDL) and none at all in a mass arbitration against the same defendant. Respondents who spent the last three years drafting arbitration clauses to escape the Class Action device would be handing funded claimants the more opaque forum. That is not an argument against the rule. It is an argument that the AAA and JAMS mass filing regimes, not the FRCP, are where the next disclosure fight belongs — and nobody is currently having it.

The state and statutory track is moving faster than the Rule 26 litigation funding disclosure rulemaking

While the committee deliberates, the states have been legislating. Insurance Journal's survey counts Georgia, Kansas, Louisiana, Indiana, Montana, Oklahoma, Wisconsin, West Virginia and New York as having laws regulating third-party litigation funding, up from seven states as of July 2025; the Times' reporting puts the number of states restricting funding in some form at more than a dozen. The regimes are not uniform: West Virginia and Wisconsin enacted automatic disclosure, Montana imposed recovery caps and prohibitions on funder influence, Indiana and Louisiana made funding agreements expressly subject to discovery while barring funder control over litigation and settlement decisions, and Georgia requires funders to register with its Department of Banking and Finance and to certify no affiliation with foreign adversaries.

New York went furthest on the consumer side. The Consumer Litigation Funding Act, A804-C/S1104A, was signed on 19 December 2025. It caps what a funding company may collect at the funded amount plus 25 per cent of gross proceeds, gives the consumer a ten-business-day right to cancel, bars funders from influencing litigation strategy, settlement decisions or attorney-client communications, and requires attorney disclosure of the gross settlement so the cap can be verified. Most substantive provisions took effect on 17 June 2026; registration with the Department of Financial Services is required by 13 February 2027.

That state activity cuts both ways in the federal debate. It supports the proponents' uniformity argument — a funder operating nationally now faces nine or more inconsistent state regimes plus three inconsistent federal district regimes. It also undercuts the urgency argument, because a plaintiff's counsel can fairly say the conduct the letter complains about is already being regulated where it actually occurs, in state-court personal injury practice, by legislatures with consumer-protection authority the Advisory Committee does not have.

One scope question will decide how much of this the federal rule even touches. Consumer legal funding — cash advances to individual injury claimants — is a different business from commercial litigation finance, and the Alliance for Responsible Consumer Legal Funding has argued to legislators that the two should not be regulated as one thing. The 26-CV-8 text does not draw that line: it reaches any nonparty "providing funding for the action" with "a financial interest therein." On its face, that captures a pre-settlement advance to a single plaintiff in a single-vehicle collision case as readily as a $40 million commercial facility, and the committee has not said which it means.

What it means for defendants, claimants' counsel, funders and PI firms

For defence counsel and corporate defendants, the operative date is 21 October 2026, not 2029. The committee's question is "disclosure to whom," and the answer determines whether a future rule delivers usable settlement intelligence or an in camera submission the defendant never sees. A comment addressed to that question is worth more now than another signature on another letter.

For claimants' counsel in aggregate practice, the exposure is retrospective. Funding agreements signed in 2026 and 2027 will still be live if a rule takes effect in December 2029, and they will be produced as written. Agreements that embed a case budget, a damages model or a consent right over settlement are the ones that will be hardest to redact, and the ones most likely to generate the privilege litigation the proposal's privilege carve-out defers rather than resolves.

For funders, 25-CV-O's control argument is now the whole ball game. The record already contains the proponents' charge that funders describe their influence differently to committees and to investors. Any submission that does not reconcile those accounts will make the case for disclosure rather than against it.

For personal injury firms running advance-funded case inventories, the immediate constraint is not federal at all. It is New York's 25 per cent cap and February 2027 registration deadline, Georgia's registration regime, and the discovery exposure that Indiana and Louisiana have already created. The federal rule is a 2029 problem; the state compliance calendar is a 2026 and 2027 one.

Frequently asked questions

What did the 214 companies ask the Advisory Committee on Civil Rules to do?

They asked the committee to draft and propose a uniform federal rule requiring disclosure of nonparty litigation funding contracts in federal civil cases, endorsing the Rule 26(a)(1)(A) amendment that Lawyers for Civil Justice and the U.S. Chamber Institute for Legal Reform submitted as suggestion 26-CV-8 on 10 March 2026.

Which companies signed the September 2026 litigation funding disclosure letter?

Insurance Journal names Allstate, AIG, Chubb, State Farm, Liberty Mutual, Nationwide, Travelers and AXA XL among the insurer signatories; Unified Patents' summary names Amazon, Google, Microsoft, Meta, ExxonMobil, Ford, Anthropic and OpenAI among the technology and industrial signatories. The letter is backed by Lawyers for Civil Justice, the U.S. Chamber Institute for Legal Reform, the American Property Casualty Insurance Association and Unified Patents. The full list of signatories has not been published.

Would the proposed rule require producing the funding agreement itself?

Yes. The 26-CV-8 text requires the funder's name, address and telephone number and, "for inspection and copying as under Rule 34," any agreement relating to the funding — so the contract terms, not only the funder's identity, would be disclosed.

When would a Rule 26 litigation funding disclosure requirement take effect?

Under the Rules Enabling Act sequence — Advisory Committee draft, Standing Committee approval, public comment, final approval, Judicial Conference, Supreme Court transmission to Congress — the earliest realistic effective date for a rule first drafted in late 2026 is 1 December 2029.

Does any rule require funder disclosure in mass arbitration?

No. The Federal Rules of Civil Procedure apply only to actions in the federal district courts, and neither the AAA Mass Arbitration Supplementary Rules nor the JAMS Mass Arbitration Procedures require a claimant to identify a funder or produce a funding agreement. A Rule 26 amendment would leave funded mass arbitration campaigns undisclosed.

Is the Advisory Committee likely to adopt a rule on 21 October 2026?

Adoption is not on the table for that date. The committee is expected to discuss next steps toward a draft rule; a draft would then need Standing Committee approval before any public comment period begins. The docket entry for suggestion 26-CV-30 indicates the committee's current focus is the narrower question of who the disclosure should be made to.

Analysis and summary only. This is not legal advice.